From press release on April 5, 2007
“The VentrAssist US BTT trial will involve up to 140 patients at leading heart transplant hospitals in America.
..............................
“The target clinical performance of the VentrAssist in the BTT trial is for 75 percent of the patients to either have a heart transplant or still be listed for heart transplant at 180 days after implant of the VentrAssist.
- Forums
- ASX - By Stock
- VCR
- dt and btt trials running together
VCR
ventracor limited
dt and btt trials running together, page-7
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VCR (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online